Dignitana AB (publ)

Stockholm Stock Exchange DIGN.ST

Dignitana AB (publ) EBITDA for the year ending December 31, 2023: USD -26.06 K

Dignitana AB (publ) EBITDA is USD -26.06 K for the year ending December 31, 2023, a 95.87% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Dignitana AB (publ) EBITDA for the year ending December 31, 2022 was USD -630.78 K, a 80.11% change year over year.
Dignitana AB (publ) EBITDA for the year ending December 31, 2021 was USD -3.17 M, a 13.44% change year over year.
Dignitana AB (publ) EBITDA for the year ending December 31, 2020 was USD -3.66 M, a -9.05% change year over year.
Dignitana AB (publ) EBITDA for the year ending December 31, 2019 was USD -3.36 M, a -80.42% change year over year.

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

Stockholm Stock Exchange: DIGN.ST

Dignitana AB (publ)

CEO	Mr. Fredrik Jonsson
IPO Date	June 18, 2009
Location	Sweden
Headquarters	Traktorgränden 3
Employees	29
Sector	Consumers Staples
Industries Personal Care Biotechnology Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Medical Instruments Pharmaceuticals Pollution Treatment

Description

Dignitana AB (publ), a medical technology company, develops, produces, and markets medical cooling devices in the United States and internationally. It offers DigniCap, a scalp cooling system used to reduce hair loss from certain chemotherapy treatments, as well as in the treatment of breast cancer. The company was incorporated in 2007 is headquartered in Lund, Sweden.

Key trends

Past 5 years